Doximity, Inc. (DOCS)

NYSE: DOCS · USD

$34.2

+0.94 (+2.8%)· Recorded snapshot

Market cap	6.1B
Revenue (ttm)	655.6M
Net income (ttm)	167M
EPS (ttm)	$0.84
Shares out	178.2M
P/E (trailing)	40.6x
P/E (forward)	23.9x
Volume	1,648,130
Beta	1.22

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 655.6M
Net income (ttm): 167M
EPS (ttm): $0.84
P/E (trailing): 40.6x
P/E (forward): 23.9x
Market cap: 6.1B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E23.9

P25 n/aP50 n/aP75 n/a

Trailing P/E40.6

P25 n/aP50 n/aP75 n/a

ROE17.2

P25 n/aP50 n/aP75 n/a

ROIC65.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All DOCS indicators

Market & fundamental data

Available fields

262

Groups with data

Currency

USD

Showing 262 of 262 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001516513
Company name	Doximity, Inc.
Country	United States
Country code	US
CUSIP number	26622P107
Earnings date	2026-11-05
Earnings time	amc
Employees	880
Employees change	50
Employees growth	6.02%
Enterprise value	$5.4B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	March
Founded	2010
Industry	Health Information Services
IPO date	2021-06-24
Is primary listing	Yes
Is SPAC	No
ISIN number	US26622P1075
Last 10-K release date	2026-05-19
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$6.1B
Market cap category	Mid-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$34.18
Price currency	USD
Sector	Healthcare
SIC code	7371
Stock price date	2026-10-28
Symbol	DOCS
U.S. state	California
Website	https://www.doximity.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	23.41x
Average P/E ratio (3Y)	38.76x
Average P/E ratio (5Y)	57.23x
Earnings yield	2.47%
EV/Earnings	31.79x
EV/EBIT	26.5x
EV/EBITDA	25.48x
EV/FCF	17.34x
EV/Sales	8.1x
FCF / EV yield	5.77%
FCF yield	5.11%
Forward EV/Sales	7.77x
Forward P/E	23.88x
Forward P/S	8.76x
Graham number	9.82657
Graham upside	-70.75%
Industry forward P/E	34.62x
Lynch fair value	$21.06
Lynch upside	-37.31%
P/(FCF - SBC) ratio	35.28x
P/(OCF - SBC) ratio	35.27x
P/B ratio	6.53x
P/E ratio	40.57x
P/FCF ratio	19.55x
P/OCF ratio	19.55x
P/S ratio	9.14x
PEG ratio	13.52x
Price / tangible book value	7.51x
Price/EBITDA ratio	28.74x
Sector forward P/E	23.53x
Sector P/E	51.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	30.57%
EBITDA margin	31.79%
Effective tax rate	26.16%
FCF margin	46.72%
Gross margin	88.07%
Operating margin	30.57%
Pretax margin	34.51%
Profit margin	25.48%
Profit per employee	$189,825
Profitable quarters	24
Profitable years	8
Revenue per employee	$744,964
ROA	10.95%
ROA (5Y)	10.49%
ROCE	21.47%
ROE	17.21%
ROE (5Y)	19.99%
ROIC	65.72%
ROIC (5Y)	130.54%
SBC / revenue	20.82%
Tax / revenue	9.03%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-27.94%
EPS growth (Q)	-51.85%
EPS growth (QoQ)	35.31%
EPS growth 3Y	14.56%
EPS growth 5Y	23.7%
EPS growth years	0
FCF growth	4.13%
FCF growth (Q)	-32.49%
FCF growth (QoQ)	-61.72%
FCF growth 3Y	17.05%
FCF growth 5Y	23.38%
Gross profit growth	8.62%
Gross profit growth (Q)	2.16%
Gross profit growth 3Y	14.63%
Gross profit growth 5Y	22.2%
Net income growth	-28.96%
Net income growth (Q)	-54.4%
Net income growth (QoQ)	27.21%
Net income growth 3Y	12.02%
Net income growth 5Y	41.4%
Net income growth years	0
OCF growth	4.16%
OCF growth (Q)	-32.39%
OCF growth (QoQ)	-61.66%
OCF growth 3Y	16.84%
OCF growth 5Y	23.32%
Operating income growth	-16.36%
Operating income growth (Q)	-38.79%
Operating income growth 3Y	14.32%
Operating income growth 5Y	21.21%
Revenue growth	11.18%
Revenue growth (Q)	7.34%
Revenue growth (QoQ)	7.74%
Revenue growth 3Y	14.49%
Revenue growth 5Y	21.94%
Revenue growth quarters	21
Revenue growth years	7

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-62,000
Depreciation and amortization	$8M
EBIT	$200.4M
EBITDA	$208.4M
EPS	$0.84
FCF per share	$1.72
Financing cash flow	$-427.5M
Free cash flow	$306.3M
Free cash flow minus SBC	$169.8M
Gross profit	$577.3M
Income taxes	$59.2M
Investing cash flow	$257.5M
Net cash flow	$136.3M
Net income	$167M
Operating cash flow minus SBC	$169.8M
Operating income	$200.4M
Revenue	$655.6M
Stock-based compensation	$136.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	31.3
Book value per share	$5.09
Debt / EBITDA	0.05
Debt / equity	0.01
Debt / FCF	0.03
Goodwill	$85M
Long-term assets	$169.9M
Long-term liabilities	$17.4M
Net cash (debt)	$678.1M
Net cash / market cap	11.32%
Net cash growth	-18.21%
Net debt / EBITDA	-3.25
Net debt / equity	-0.74
Net debt / FCF	-2.21
Piotroski F-Score	5
Property, plant and equipment	$26M
Shareholders' equity	$916.1M
Tangible book value	$797.7M
Tangible book value per share	$4.44
Total assets	$1.1B
Total cash	$687.8M
Total debt	$9.7M
Total liabilities	$167.8M
WACC	10.92%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.57
Current assets	$914M
Current liabilities	$150.4M
Current ratio	6.08
Net working capital	$78M
Quick ratio	5.8
Working capital	$763.6M
Working capital turnover	0.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.55%
Dividend yield	0%
Shareholder yield	2.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$24.21
1D price change	2.83%
1M price change	29.72%
1M total return	29.72%
1W price change	2.49%
1W total return	2.49%
1Y price change	-50.1%
1Y return CAGR	-50.13%
1Y total return	-50.1%
20-day SMA	$30.99
200-day SMA	$25.63
3M price change	62.84%
3M total return	62.84%
3Y price change	64.49%
3Y return CAGR	18.04%
3Y total return	64.49%
50-day SMA	$28.00
50-day SMA vs 200-day SMA	50over200
52-week high	$69.00
52-week high date	2025-10-28
52-week low	$17.15
52-week low date	2026-05-14
5Y price change	-49.06%
5Y return CAGR	-12.62%
5Y total return	-49.06%
6M price change	38.61%
6M total return	38.61%
All-time high	$107.79
All-time high date	2021-09-10
All-time low	$17.15
All-time low date	2026-05-14
Average true range (ATR)	$1.22
Average volume	2.9M
Beta (1Y)	1.92
Beta (2Y)	1.73
Beta (5Y)	1.22
Change from 52-week high	-50.46%
Change from 52-week low	99.3%
Change from all-time high	-68.29%
Change from all-time low	99.3%
Change from open	2.98%
Day's gap	-0.15%
Dollar volume	$56.3M
High price	$34.21
Low price	$33.18
Monthly RSI	47.11
Open price	$33.19
Position in 52-week range	97.09%
Premarket change	-0.69%
Premarket close	$33.24
Premarket price	$33.01
Premarket volume	29.9K
Previous close	$33.24
Price vs 150-day SMA	41.17%
Price vs 20-day SMA	10.29%
Price vs 200-day SMA	33.39%
Price vs 50-day SMA	22.08%
Relative volume	0.56
Return from IPO open	-18.39%
Return from IPO price	29.23%
RSI	73.66
Sharpe ratio	-0.82
Sharpe ratio (3Y)	0.46
Sharpe ratio (5Y)	0.02
Sortino ratio	-1.07
Sortino ratio (3Y)	0.92
Sortino ratio (5Y)	0.13
Volume	1.6M
Weekly RSI	64.94
YTD price change	-22.81%
YTD total return	-22.81%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	123.6M
Float percentage	69.36%
Shares change (QoQ)	-1.98%
Shares change (YoY)	-2.55%
Shares held by insiders	28.87%
Shares held by institutions	74.49%
Shares outstanding	178.2M
Short % of float	9.13%
Short % of shares	6.33%
Short ratio	4 days

Deeper analysis on DOCS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this DOCS report

Is a complete DOCS research report available?

No complete published report is available for Doximity, Inc. (DOCS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Doximity, Inc. (DOCS)

Price

Financial snapshot

Fair-value bridge

Latest news · DOCS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DOCS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DOCS

Frequently asked questions